Clinicians report success with first test of drug in a patient with life-threatening blood clotting disorder

A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura.

Clinicians report success with first test of drug in a patient with life-threatening blood clotting disorder
A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow